Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-22-006515

Options or other derivatives

  • Chief Executive Officer acquired 1,489,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-02-01 Grant or award : show line 1 in the form Stock Option (right to buy) +1,489,700 1,489,700 D
Loading xslF345X03/doc4.xml…